Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-06

Clinical Trial Update: A Phase Ⅱa Clinical Study of CL-197 Capsules [Phase 2]

View source ↗

Summary

A Phase 2a clinical trial of CL-197 capsules for HIV infection is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CL-197

Snippet

Sponsor: Henan Genuine Biotech Co., Ltd. | Conditions: HIV-1 Infection | Phase 2 | Status: RECRUITING